Publications by authors named "Maeve Lowery"

Claim this Profile
F
First-line pembrolizumab plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction adenocarcinoma: Health-related quality of life from the randomized phase III KEYNOTE-859 trial.
Maeve A Lowery, Lucjan S Wyrwicz, Do-Youn Oh, Kai-Keen Shiu, Patricio Yañez

Eur J Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of Resistance to PARPi in Pancreatic Ductal Adenocarcinoma.
Jojanneke Stoof, Charlotte Andrieu, Fiona O'Connell, Jacintha O'Sullivan, Maeve A Lowery

J Cell Mol Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to "New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe" [The Lancet Regional Health - Europe, volume 50, March 2025, 101170].
Lorenza Rimassa, Angela Lamarca, Grainne M O'Kane, Julien Edeline, Mairéad G McNamara, Maeve A Lowery

Lancet Reg Health Eur· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Fibrolamellar Cancer Registry: Opportunities and Challenges.
Layal Al Mahmasani, Marinela Capanu, Kurt Losert, Joanne F Chou, Maeve Aine Lowery

JCO Glob Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overview of Molecular Diagnostics in Irish Clinical Oncology.
Tyler Medina, Seán O Hynes, Maeve Lowery, Patrick Gillespie, Walter Kolch

HRB Open Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe.
Lorenza Rimassa, Angela Lamarca, Grainne M O'Kane, Julien Edeline, Mairéad G McNamara, Maeve A Lowery

Lancet Reg Health Eur· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for the Positive Impact of Centralization in Esophageal Cancer Surgery.
Noel E Donlon, Brendan Moran, Maria Davern, Matthew G Davey, Czara Kennedy, Maeve Lowery

Ann Surg· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Review of Economic Evaluations of Systemic Treatments for Advanced and Metastatic Gastric Cancer.
Shikha Sharma, Niamh Carey, David McConnell, Maeve Lowery, Jacintha O'Sullivan

Pharmacoeconomics· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab in HER2-Positive Gastric Cancer.
Yelena Y Janjigian, Akihito Kawazoe, Yuxian Bai, Jianming Xu, Sara Lonardi, Maeve Lowery

N Engl J Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-checkpoint blockade in surgical management of gastric or gastro-oesophageal junction adenocarcinoma.
Maeve A Lowery

Lancet Gastroenterol Hepatol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modifiable risk factors for cancer among people with lynch syndrome: an international, cross-sectional survey.
Robert F Power, Damien E Doherty, Roberta Horgan, Pat Fahey, David J Gallagher, Maeve A Lowery

Hered Cancer Clin Pract· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PCM4EU and PRIME-ROSE: Collaboration for implementation of precision cancer medicine in Europe.
Kjetil Taskén, Soemeya F Haj Mohammad, Gro Live Fagereng, Ragnhild Sørum Falk, Åslaug Helland, Maeve A Lowery

Acta Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modifiable Risk Factors and Risk of Colorectal and Endometrial Cancers in Lynch Syndrome: A Systematic Review and Meta-Analysis.
Robert F Power, Damien E Doherty, Imelda Parker, David J Gallagher, Maeve A Lowery

JCO Precis Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health diplomacy in action: The cancer legacy of the Good Friday Agreement.
Mark Lawler, Richard Sullivan, Ghassan K Abou-Alfa, Karen McCloskey, Debbie Keatley, Maeve Lowery

J Cancer Policy· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial.
John V Reynolds, Shaun R Preston, Brian O'Neill, Maeve A Lowery, Lene Baeksgaard

Lancet Gastroenterol Hepatol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial.
Sun Young Rha, Do-Youn Oh, Patricio Yañez, Yuxian Bai, Min-Hee Ryu, Maeve A Lowery

Lancet Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visceral adipose tissue secretome from early and late-stage oesophageal cancer patients differentially affects effector and regulatory T cells.
Maria Davern, Dara Bracken-Clarke, Noel E Donlon, Andrew D Sheppard, Fiona O' Connell, Maeve Lowery

J Cancer Res Clin Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient knowledge, personal experience, and impact of the first wave of the COVD-19 pandemic in an Irish oncology cohort.
Ruth Kieran, Carolyn Moloney, Scheryll Alken, Lynda Corrigan, David Gallagher, Maeve A Lowery

Ir J Med Sci· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus statement on the surveillance of patients with gastrointestinal malignancies.
Fergus Keane, Megan Greally, Anne Horgan, Karen Duffy, Maeve Lowery

Ir J Med Sci· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CROSS Versus FLOT Regimens in Esophageal and Esophagogastric Junction Adenocarcinoma: A Propensity-Matched Comparison.
Noel E Donlon, Brendan Moran, Anitha Kamilli, Maria Davern, Andrew Sheppard, Maeve Lowery

Ann Surg· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What is the gender representation in authorship in later phase systemic clinical trials in biliary tract cancer (BTC)? - a retrospective review of the published literature.
Mairéad G McNamara, John Bridgewater, Lipika Goyal, Timothy Jacobs, Anna D Wagner, Maeve Lowery

BMJ Open· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moving the Needle on Precision Medicine in Pancreatic Cancer.
Grainne M O'Kane, Maeve A Lowery

J Clin Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting MET amplification in Gastro-oesophageal (GO) malignancies and overcoming MET inhibitor resistance: challenges and opportunities.
Emily Harrold, Lynda Corrigan, Simon Barry, Maeve Lowery

Expert Rev Gastroenterol Hepatol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacologically controlling protein-protein interactions through epichaperomes for therapeutic vulnerability in cancer.
Suhasini Joshi, Erica DaGama Gomes, Tai Wang, Adriana Corben, Tony Taldone, Maeve Lowery

Commun Biol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA Damage Repair Deficiency in Pancreatic Ductal Adenocarcinoma: Preclinical Models and Clinical Perspectives.
Jojanneke Stoof, Emily Harrold, Sarah Mariottino, Maeve A Lowery, Naomi Walsh

Front Cell Dev Biol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis